|
1
|
Mao Y, Yang D, He J and Krasna MJ:
Epidemiology of lung cancer. Surg Oncol Clin N Am. 25:439–345.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rivera GA and Wakelee H: Lung cancer in
never smokers. Adv Exp Med Biol. 893:43–57. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Glinski K, Socha J, Wasilewska-Tesluk E,
Komosinska K and Kepka L: Accelerated hypofractionated radiotherapy
with concurrent full dose chemotherapy for locally advanced
non-small cell lung cancer: A phase I/II study. Radiother Oncol.
148:174–180. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kehoe S, Hook J, Nankivell M, Jayson GC,
Kitchener H, Lopes T, Luesley D, Perren T, Bannoo S, Mascarenhas M,
et al: Primary chemotherapy versus primary surgery for newly
diagnosed advanced ovarian cancer (CHORUS): An open-label,
randomised, controlled, non-inferiority trial. Lancet. 386:249–257.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li FS, Zhang YL, Li Z, Xu D, Liao CY, Ma
H, Gong L, Su J, Sun Q, Xu Q, et al: Randomized, double-blind,
placebo-controlled superiority trial of the Yiqigubiao pill for the
treatment of patients with chronic obstructive pulmonary disease at
a stable stage. Exp Ther Med. 12:2477–2488. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang L, Li F, Sun J, Huo H, Li X and Li
H: Efficacy of Yiqigubiao pill on chronic obstructive pulmonary
disease in rats with the disease induced by lipopolysaccharide and
cigarette-smoke fumigation. J Tradit Chin Med. 40:983–991.
2020.PubMed/NCBI
|
|
7
|
Boezio B, Audouze K, Ducrot P and
Taboureau O: Network-based approaches in pharmacology. Mol Inform.
36:2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kibble M, Saarinen N, Tang J, Wennerberg
K, Mäkelä S and Aittokallio T: Network pharmacology applications to
map the unexplored target space and therapeutic potential of
natural products. Nat Prod Rep. 32:1249–1266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu Y, Zhang F, Yang K, Fang S, Bu D, Li H,
Sun L, Hu H, Gao K, Wang W, et al: SymMap: An integrative database
of traditional Chinese medicine enhanced by symptom mapping.
Nucleic Acids Res. 47(D1): D1110–D1117. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye H, Ye L, Kang H, Zhang D, Tao L, Tang
K, Liu X, Zhu R, Liu Q, Chen YZ, et al: HIT: Linking herbal active
ingredients to targets. Nucleic Acids Res. 39((Database Issue)):
D1055–D1059. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Keiser MJ, Roth BL, Armbruster BN,
Ernsberger P, Irwin JJ and Shoichet BK: Relating protein
pharmacology by ligand chemistry. Nat Biotechnol. 25:197–206. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Amberger JS, Bocchini CA, Schiettecatte F,
Scott AF and Hamosh A: OMIM.org: Online mendelian inheritance in
man (OMIM®), an online catalog of human genes and
genetic disorders. Nucleic Acids Res. 43((Database Issue)):
D789–D798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou J and Rudd KE: EcoGene 3.0. Nucleic
Acids Res. 41((Database Issue)): D613–D624. 2013.PubMed/NCBI
|
|
14
|
The UniProt Consortium: UniProt: The
universal protein knowledgebase. Nucleic Acids Res. 45(D1):
D158–D169. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
The Gene Ontology Consortium: Expansion of
the gene ontology knowledgebase and resources. Nucleic Acids Res.
45(D1): D331–D338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kang Y, Zhu X, Xu Y, Tang Q, Huang Z, Zhao
Z, Lu J, Song G, Xu H, Deng C and Wang J: Energy stress-induced
lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and
inhibits osteosarcoma progression. Am J Cancer Res. 8:526–537.
2018.PubMed/NCBI
|
|
20
|
Li S and Zhang B: Traditional Chinese
medicine network pharmacology: Theory, methodology and application.
Chin J Nat Med. 11:110–120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang R, Zhu X, Bai H and Ning K: Network
pharmacology databases for traditional Chinese medicine: Review and
assessment. Front Pharmacol. 10:1232019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang S, Ma Y, Hu X, Zheng Y and Chen X:
Targeting PRMT5/Akt signalling axis prevents human lung cancer cell
growth. J Cell Mol Med. 23:1333–1342. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Olivier M, Hollstein M and Hainaut P: TP53
mutations in human cancers: Origins, consequences, and clinical
use. Cold Spring Harb Perspect Biol. 2:a0010082010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng ZH, Wu DM, Fan SH, Zhang ZF, Chen GQ
and Lu J: Upregulation of miR-675-5p induced by lncRNA H19 was
associated with tumor progression and development by targeting
tumor suppressor p53 in non-small cell lung cancer. J Cell Biochem.
120:18724–18735. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du X, Shao Y, Qin HF, Tai YH and Gao HJ:
ALK-rearrangement in non-small-cell lung cancer (NSCLC). Thorac
Cancer. 9:423–430. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, Zhou Y, Ma L, Cao S, Gao W, Xiong
Q, Wang K and Yang L: CIAPIN1 targeted NHE1 and ERK1/2 to suppress
NSCLC Cells' metastasis and predicted good prognosis in NSCLC
patients receiving pulmonectomy. Oxid Med Cell Longev.
2019:19708182019.PubMed/NCBI
|
|
27
|
Moncho-Amor V, Pintado-Berninches L,
Ibañez de Cáceres I, Martín-Villar E, Quintanilla M, Chakravarty P,
Cortes-Sempere M, Fernández-Varas B, Rodriguez-Antolín C, de Castro
J, et al: Role of dusp6 phosphatase as a tumor suppressor in
non-small cell lung cancer. Int J Mol Sci. 20:20362019. View Article : Google Scholar
|
|
28
|
Sun C, Li C, Li X, Zhu Y, Su Z, Wang X, He
Q, Zheng G and Feng B: Scutellarin induces apoptosis and autophagy
in NSCLC cells through ERK1/2 and AKT signaling pathways in vitro
and in vivo. J Cancer. 9:3247–3256. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang H, Bai Y, Pan G, Wang X, Wei Y, Yang
Z and Zhao J: Interleukin-6 and insulin-like growth factor-1
synergistically promote the progression of NSCLC. Autoimmunity.
51:399–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xie Y, Shi X, Sheng K, Han G, Li W, Zhao
Q, Jiang B, Feng J, Li J and Gu Y: PI3K/Akt signaling transduction
pathway, erythropoiesis and glycolysis in hypoxia (Review). Mol Med
Rep. 19:783–791. 2019.PubMed/NCBI
|
|
31
|
Wu DM, Zhang T, Liu YB, Deng SH, Han R,
Liu T, Li J and Xu Y: The PAX6-ZEB2 axis promotes metastasis and
cisplatin resistance in non-small cell lung cancer through PI3K/AKT
signaling. Cell Death Dis. 10:3492019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sparvero LJ, Asafu-Adjei D, Kang R, Tang
D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ and Lotze
MT: RAGE (receptor for advanced glycation endproducts), RAGE
ligands, and their role in cancer and inflammation. J Transl Med.
7:172009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zeng T, Chen C, Yang P, Zuo W, Liu X and
Zhang Y: A protective role for RHOJ in nonsmall cell lung cancer
based on integrated bioinformatics analysis. J Comput Biol.
27:1092–1103. 2020. View Article : Google Scholar : PubMed/NCBI
|
